Cervical Cancer Content
Pembrolizumab and Chemotherapy in Cervical Cancer: A New Standard of Care?
touchREVIEWS in Oncology & Haematology. 2022;18(1):2–8
Cervical cancer (CC) remains one of the most frequent cancers in women, representing the fourth cause of neoplasia in women in terms of incidence, and has a high lethality rate.1 Indeed, worldwide 341,831 women die each year because of this disease, with a mortality rate that varies across different countries, with, for example, less than two […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!